Tamási, Lilla http://orcid.org/0000-0003-3477-6125
Bartha, Anna
Ferencz, Aranka
Tímár, Mihály
Vahteristo, Mikko
Takala, Aino
Müller, Veronika
Funding for this research was provided by:
Orion Corporation, Espoo, Finland
Article History
Received: 19 July 2022
Accepted: 3 October 2022
First Online: 1 November 2022
Declarations
:
: We acknowledge all the authors and study participants for their input into the development, conduct and reporting of this real-world study in Hungary.
: Sponsorship of this study including the Rapid Service and Open Access fees for the journal were funded by Orion Corporation, Espoo, Finland.
: Medical writing and editorial assistance was funded by Orion Corporation and provided by Robert Christopher Gardner Ph.D, Bioscript Group, Macclesfield, UK.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
: All authors contributed to study conception, study design and data collection. Data analysis and interpretation was led by M.V. and A.T. with input from other authors. The writing of the original draft was led by M.V. and A.T. and the reviewing and editing of manuscript drafts was conducted by all authors. All authors have read and agree to the published version of the manuscript.
: L. Tamási is an employee of Department of Pulmonology, Semmelweis University Faculty of Medicine, Budapest, Hungary. In the last 5 years, LT has received lecture or consultancy fees and/or support for conference attendance from Orion Corporation, Novartis, GlaxoSmithKline, Chiesi, Boehringer Ingelheim, Teva Pharmaceutical, and AstraZeneca. A. Bartha is an employee of Siófok Hospital and Outpatient Clinic of Pulmonology, Siófok, Hungary. A. Ferencz is an employee of Ferenc Toldy Hospital and Outpatient Clinic of Pulmonology, Cegléd, Hungary. M. Tímár is an employee of Hungarian Army Medical Center, Budapest, Hungary. V. Muller is an employee of Department of Pulmonology, Semmelweis University Faculty of Medicine, Budapest, Hungary, has received lecture or consultancy fees and/or support for conference attendance from Orion Corporation, Novartis, GlaxoSmithKline, Chiesi, Boehringer Ingelheim, Teva Pharmaceuticals, and AstraZeneca. A. Takala, M. Vahteristo, are employees of Orion Corporation, Espoo, Finland.
: This study was conducted in accordance with ethical principles of the Declaration of Helsinki and International Conference on Harmonization (ICH) Good Clinical Practice (GCP) guidelines. The study protocol was approved by the local Ethics Committee in Hungary: Scientific and Research Ethics Committee and National Institute of Food and Drug administration, OGYÉI/13041–5/2019. All patients provided written informed consent in Hungarian.
: The data generated for this study is the property of Semmelweis University and is not publicly available.